rosiglitazone has been researched along with adenosine diphosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Garg, BS; Goel, S; Jain, SC; Olsen, CE; Parmar, VS; Raj, HG; Sharma, RK; Singh, A; Tyagi, YK; Wengel, J | 1 |
Arora, S; Chatterjee, S; Kumar, A; Majumder, S; Parmar, VS; Prasad, AK; Raj, HG; Saluja, D; Saso, L; Tyagi, YK | 1 |
Joshi, R; Kumar, A; Manral, S; Parmar, VS; Prasad, AK; Raj, HG; Rohil, V; Singh, U; Sinha, R; Sushama, A | 1 |
3 other study(ies) available for rosiglitazone and adenosine diphosphate
Article | Year |
---|---|
Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part 3: A novel mechanism for the inhibition of biological membrane lipid peroxidation by dioxygenated 4-methylcoumarins mediated by the formation of a stable ADP-Fe-inhibitor mixed
Topics: Adenosine Diphosphate; Animals; Antioxidants; Carbon Tetrachloride; Coumarins; Iron; Kinetics; Ligands; Lipid Peroxidation; Lung; Male; Microsomes, Liver; Paraquat; Rats; Rats, Wistar; Structure-Activity Relationship; Superoxides; Thiobarbituric Acid Reactive Substances | 1998 |
The role of calreticulin transacetylase in the activation of human platelet nitrite reductase by polyphenolic acetates.
Topics: Acetyltransferases; Adenosine Diphosphate; Antioxidants; Blood Platelets; Calreticulin; Coumarins; Cyclic GMP; Electrodes; Enzyme Activation; Flavonoids; Flow Cytometry; Humans; NADPH-Ferrihemoprotein Reductase; Nitric Oxide; Nitric Oxide Synthase; Nitrite Reductases; Phenols; Platelet Aggregation; Polyphenols | 2009 |
Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Topics: Acetates; Acetylation; Acetyltransferases; Adenosine Diphosphate; Arginine; Blood Platelets; Cells, Cultured; Coumarins; Cyclic GMP; Cytochrome Reductases; Enzyme Inhibitors; Fluoresceins; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Platelet Aggregation; Polyphenols; Structure-Activity Relationship | 2012 |